...
首页> 外文期刊>Acta orthopaedica. >Implant survival and patient-reported outcome following total hip arthroplasty in patients 30 years or younger: a matched cohort study of 1,008 patients in the Swedish Hip Arthroplasty Register
【24h】

Implant survival and patient-reported outcome following total hip arthroplasty in patients 30 years or younger: a matched cohort study of 1,008 patients in the Swedish Hip Arthroplasty Register

机译:30岁或更年轻的患者进行全髋关节置换术后的植入物存活率和患者报告的结果:瑞典髋关节置换术登记系统中对1,008例患者的配对队列研究

获取原文
           

摘要

Background and purpose — The outcome of total hip arthroplasty (THA) in younger patients is suggested to be inferior compared with the general THA population. There is a lack of studies with long-term follow up for very young patients. We report on implant survival and patient-reported outcome in patients aged 30 years or younger.Patients and methods — Data on THAs performed in Sweden between the years 2000 and 2016 were included. There were 504 patients 30 years or younger with complete demographic and surgical data (study group). A matched comparison group older than 30 years was identified. Implant survival was analyzed using the Kaplan–Meier method. Patient-reported outcome was analyzed in a subgroup of patients.Results — The 10-year and 15-year implant survivorship for the study group was 90% and 78%, respectively. The corresponding figures for the patients older than 30 years were 94% and 89%. The median preoperative EQ-5D index was lower in the study group; the improvement in EQ-5D index was similar between the study and the comparison groups. The preoperative EQ-VAS was lower and the improvement in EQ-VAS at 1 year was larger in the study group.Interpretation — The promising 10-year implant survival and 1-year improvement in patient-reported outcome suggests that THA is a feasible option in the patients 30 years or younger.
机译:背景与目的—与一般THA人群相比,年轻患者的全髋关节置换术(THA)的结果较差。对于非常年轻的患者,缺乏长期随访的研究。我们报告了30岁或30岁以下的患者的植入物存活率和患者报告的结局。有504名30岁以下的患者具有完整的人口统计学和外科手术数据(研究组)。确定了一个匹配的年龄超过30岁的对照组。使用Kaplan-Meier方法分析植入物的存活率。在患者亚组中分析了患者报告的结局。结果—研究组的10年和15年植入物存活率分别为90%和78%。 30岁以上患者的相应数字分别为94%和89%。研究组的术前EQ-5D指数中位数较低;研究组和对照组之间EQ-5D指数的改善相似。在研究组中,术前EQ-VAS较低,在1年时EQ-VAS的改善较大。解释-有希望的10年植入物存活率和患者报告的结局1年改善表明THA是一种可行的选择在30岁以下的患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号